http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026222-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59167332940b6ad7a37e4c0306e249b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84cc2f70943a8c4b0986965931dec3cd |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q1-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-347 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34 |
| filingDate | 2003-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82fa2305efb125294eca221714aab040 |
| publicationDate | 2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004026222-A3 |
| titleOfInvention | Compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly $g(e)-viniferin, and/or certain derivatives thereof |
| abstract | The invention relates to compositions which are used to care for skin suffering from a hormonal imbalance and which contain one or more resveratrol oligomers, particularly ε-viniferin, and/or certain derivatives thereof. Hormonal imbalances have negative effects on the condition of the skin, nails, hair, lips, external genital organs, oral mucous membranes, and the menopause essentially causes relatively significant hormonal imbalances. Products containing those hormones which the skin lacks have been developed solely in the pharmaceutical field as said hormones are prohibited for use in cosmetics. Non-steroid phytohormones have also been used, but most research with said products has been carried out by means of oral treatment. There has been no very explicit research relating to topical treatments. Retinoids represent another category of molecules which are used to treat the cutaneous symptoms of hormonal imbalances but retinoid acid is prohibited in cosmetics as it is teratogenic and extremely irritant. However, research has been carried out, and patents issued, relating to products based on a stilbene, namely Resveratrol. A test performed on the skin of post-menopausal women, non-substituted, shows that ε-viniferin (a dimer of Resveratrol) and a vegetable extract containing same produce hormonal and retinoid effects on the deficient skin. This type of activity has never been described before. The invention relates to cosmetic products, pharmaceutical products and food supplements which are intended to prevent and combat the negative effects caused by a hormonal imbalance affecting the skin and the appendages thereof. The inventive compositions contain at least one Resveratrol oligomer and/or one derivative and/or one vegetable extract containing same. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109769802-B |
| priorityDate | 2002-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.